Press-release for stocks publishing date 2023 - 02

PTC Therapeutics to Participate at Upcoming Investor Conference
Published: 2023-02-02 (Crawled : 22:00) - prnewswire.com
PTCT | News S | $25.41 -2.16% -2.32% 0

Health Technology

| -45.15% | O: -1.06% H: 2.94% C: 2.52%
conference therapeutics

Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
Published: 2023-02-02 (Crawled : 22:00) - globenewswire.com
UTHR | $234.47 0.18% 0.16% 1

Health Technology

| -9.64% | O: -0.1% H: 1.37% C: -2.48%
LQDA S | $12.95 -1.75% -1.7% 430

Health Technology

| 84.74% | O: 1.71% H: 3.37% C: 0.0%
patent trial therapeutics

Sorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
Published: 2023-02-02 (Crawled : 20:00) - globenewswire.com
SCLX | $0.9767 2.66% 3.31% 110K

| -87.44% | O: -1.41% H: 7.28% C: 0.39%
BNPQF | News | $70.45 2.76% -13.4% 0

Finance

| 1.23% | O: -3.56% H: 0.0% C: -2.73%
BNPQY | News | $36.46 2.47% -2.68% 19

Finance and Insurance

| 8.67% | O: -0.75% H: 0.75% C: -0.18%
UBS | News J | $28.39 1.5% -2.96% 17K

Finance

| 32.6% | O: -0.88% H: 1.58% C: 0.93%
MS | News | $93.76 1.81% 0.0% 5.5K

Finance

| -5.49% | O: -0.98% H: 1.97% C: 1.21%
SRNE | $0.015 -8.85% 0

Health Technology

| -99.02% | O: -1.96% H: 6.0% C: 2.0%
AMAL | News | $23.37 1.39% 6.2K

Finance

| 0.26% | O: -0.17% H: 0.35% C: 0.13%

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
Published: 2023-02-02 (Crawled : 19:00) - globenewswire.com
SCLX | $0.9767 2.66% 3.31% 110K

| -87.44% | O: -1.41% H: 7.28% C: 0.39%
BNPQF | News | $70.45 2.76% -13.4% 0

Finance

| 1.23% | O: -3.56% H: 0.0% C: -2.73%
BNPQY | News | $36.46 2.47% -2.68% 19

Finance and Insurance

| 8.67% | O: -0.75% H: 0.75% C: -0.18%
XYF | News | $3.8825 -0.45% 0

Finance

| -0.71% | O: 0.06% H: 3.32% C: 0.51%
UBS | News J | $28.39 1.5% -2.96% 17K

Finance

| 32.6% | O: -0.88% H: 1.58% C: 0.93%
USB A | $40.97 -0.19% -0.98% 4.1K

Finance

| -16.64% | O: -0.67% H: 1.63% C: 0.98%
MS | News | $93.76 1.81% 0.0% 5.5K

Finance

| -5.49% | O: -0.98% H: 1.97% C: 1.21%
DB | $16.395 -0.64% 90K

Finance

| 31.16% | O: -0.64% H: 0.6% C: -0.56%
SRNE | $0.015 -8.85% 0

Health Technology

| -99.02% | O: -1.96% H: 6.0% C: 2.0%
AMAL | News | $23.37 1.39% 6.2K

Finance

| 0.26% | O: -0.17% H: 0.35% C: 0.13%

Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
Published: 2023-02-02 (Crawled : 17:00) - biospace.com/
SAGE | $12.95 0.47% 0.39% 8.9K

Health Technology

| -71.0% | O: 0.96% H: 0.0% C: -1.11%
report year therapeutics financial results

Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
YMAB | $15.34 510K

Health Technology

| 230.6% | O: 0.43% H: 4.29% C: 3.43%
agreement

Coya Therapeutics, Inc. to Present Proof of Concept Clinical Data at Multiple Scientific Conferences Throughout 2023
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
COYA | News | $8.02 0.38% 0.06% 0

| 95.94% | O: 5.5% H: 0.73% C: -3.66%

The Global Antipsychotic Drugs Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
ATAI | $1.89 -4.06% 160K

Manufacturing

| 7.07% | O: 1.63% H: 6.95% C: 4.81%
VTRS | News A | $11.36 0.98% 0.97% 210

Health Technology

| -7.34% | O: -0.16% H: 0.08% C: -0.41%
BMY | $48.72 -0.55% 250K

Health Technology

| -31.22% | O: -1.28% H: 3.64% C: 3.48%
ABBV | News | $168.48 -0.63% 110K

Health Technology

| 15.65% | O: -0.46% H: 0.0% C: -0.75%
ACER | $0.9 -3.61% 420K

Health Technology

| -60.53% | O: -0.88% H: 2.65% C: -3.98%
global growth market

Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
CMPX | $1.52 2.01% 1.32% 1

Professional, Scientific, and T...

| -61.9% | O: 4.76% H: 1.32% C: -5.02%
biopharma global conference therapeutics

Gain Therapeutics to Participate in Upcoming Scientific and Medical ConferencesGain to present new preclinical data on its lead programs in GBA1-related diseases
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
GANX | $3.39 6.94% 6.21% 0

Professional, Scientific, and T...

| -14.61% | O: 3.27% H: 0.98% C: -5.61%
preclinical medical therapeutics

GT Biopharma Issues Open Letter to Shareholders Detailing Recent Activities
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
GTBP | $3.65 -3.44% -2.44% 0

Manufacturing